Earnings Overview
Healthcare Realty Trust Inc (NYSE:HR) released its first quarter 2026 results on April 30, 2026. The company reported revenue of $278.99 million, falling short of the analyst consensus estimate of $282.59 million by approximately $3.6 million. Revenue growth remains a concern relative to expectations for the quarter.
On the earnings front, Healthcare Realty posted Non-GAAP EPS of $0.41 per share. Notably, this far exceeded the Wall Street estimate, which had forecast a loss of $0.0371 per share. The positive earnings surprise of over $0.44 per share stands out as the headline takeaway from the report.
Guidance and Outlook
Management raised its full-year 2026 Normalized FFO guidance to a range of $1.59 to $1.65 per diluted share (midpoint of $1.62), a $0.01 increase at the midpoint from prior guidance. The company also lifted its Same Store Cash NOI growth guidance to a range of 3.75% to 4.75%, representing a 25-basis-point increase. The analysts’ full-year 2026 sales estimate currently sits at $1.177 billion, which would imply a decline of approximately 14.4% from the prior year. This discrepancy between improved operational guidance and top-line revenue estimates is a key dynamic to watch.
For the second quarter of 2026, analysts project revenue of $282.98 million, which suggests a sequential improvement of roughly 1.4% from Q1 actuals. No specific Q2 earnings guidance was provided in the release, but the full-year FFO range implies stability through the remainder of the year.
Valuation Metrics
From a valuation standpoint, Healthcare Realty’s price-to-book ratio stands at 1.05, placing it near net asset value. The company offers a dividend yield of 5.15%, which may appeal to income-oriented investors. The trailing twelve-month (TTM) price-to-sales ratio is 2.89. While these metrics are not the focus of this earnings review, they provide context for where the stock trades against its fundamentals.
Analyst Views
The consensus analyst estimates for revenue showed an expectation of slight revenue pressure, which materialized with the miss on the top line. However, the massive earnings beat (swinging from an expected loss to positive EPS) likely overshadowed the revenue shortfall. The upward revision to full-year guidance further reinforces the positive narrative. Analysts may revise their near-term projections upward, especially for earnings, given the strong operational execution. Key areas of focus will be whether the revenue trajectory can improve in coming quarters to align with management’s cash flow growth outlook.
Market Reaction
The stock’s performance leading into the earnings release was positive. In the past month, shares gained 8.6%, while the two-week performance shows a 3.6% increase, and the last week added 0.82%. The after-market reaction following the release remained flat (0.0%), which may reflect the mixed nature of the report—strong earnings and raised guidance countered by a revenue miss. Market participants appear to be weighing these factors, with no immediate directional bias post-announcement.
Key Takeaways from the Press Release
- Reported Q1 2026 revenue of $278.99 million (below estimates of $282.59 million).
- Non-GAAP EPS of $0.41, well above the estimated loss of $0.0371.
- Raised full-year 2026 Normalized FFO guidance to $1.59–$1.65 per share (midpoint $1.62).
- Increased Same Store Cash NOI growth guidance range to 3.75%–4.75%, up 25 bps.
- Company noted continued operational momentum and favorable leasing trends in high-growth markets.
For a detailed look at Healthcare Realty’s historical earnings trends and future projections, including analyst estimates and consensus data, visit the earnings page and the forecast & ratings page.
View Historical Earnings Data
See Future Estimates and Analyst Ratings
This article is provided for informational purposes only and does not constitute investment advice. Always conduct your own research and consult with a financial professional before making investment decisions.